Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation
NCT05499637Phase 2Terminated
- Start
- Jan 2023
- Primary completion
- Sep 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentixafor in acute cellular rejection of cardiac allograft (ACR), cardiac sarcoidosis (CS), myocarditis. Started Jan 2023; status: terminated.
02
Drugs
pentixafor
03
Conditions
acute cellular rejection of cardiac allograft (ACR)cardiac sarcoidosis (CS)myocarditis
Beyond the preview
Go deeper on NCT05499637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05499637.